1 0

    FDA 23ANDME AUTHORIZATION TO MARKET DIRECT-TO-CONSUMER GENETIC TESTS 2013 TO PRESENT

    FDA 23ANDME AUTHORIZATION TO MARKET DIRECT-TO-CONSUMER GENETIC TESTS 2013 TO PRESENT

    $69.00 USD
    $69.00 USD
    Sale Sold out
    Original Request: Any and all documents, from January 1, 2013 to present, related to the U.S. Food and Drug Administration (FDA)s authorization of 23andMe to market direct-to-consumer, health-related genetic tests in the United States.
    Tags: MedTech, DeNovo, 2013
    • Status: Pending Fast-Track Request
    • Delivery: Approximately 1 to 2 weeks when the FOIA office is operating at regular capacity

    NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.

    View full details